<DOC>
	<DOCNO>NCT00156533</DOCNO>
	<brief_summary>We want assess whether `` '' one take sleep medication result similar different outcome respect symptom relief . We also want know whether take medication period time provide continued benefit medication stop .</brief_summary>
	<brief_title>Long Term Treatment With Zolpidem : Nightly Intermittent Dosing</brief_title>
	<detailed_description>To date , aggressive treatment ( Tx ) chronic insomnia evaluate term whether maintenance therapy possible . While constitutes maintenance therapy matter debate , two study show benzodiazepine receptor agonist ( BZRAs ) 1 ) effective use intermittently 3 month 2 ) may use nightly basis 6 month loss efficacy . The significance present research two fold . First , allow u compare two primary strategy use long term treat insomnia ( nightly dose vs intermittent dosing ) . Second , allow evaluation possibility extend treatment , give careful withdrawal medication , may yield long term clinical gain . Re : Objective 1 : It widely assume intermittent dose confers increase efficacy . That , less frequent medication use extend duration time medication maximally potent . An empirical assessment proposition require . If incorrect , physicians patient encourage adopt aggressive approach treatment . If correct , physicians patient encourage adopt intermittent dose approach treatment . Re : Objective 2 : It widely assume treatment sedative ( sleep promoting medication ) constitute palliative care . An empirical assessment proposition require . If correct , physicians patient encourage adopt aggressive approach long term treatment . If incorrect , physicians patient encourage adopt approach treatment currently standard practice : extend treatment clear plan taper medication design maintain clinical gain occur medication use . We propose evaluate issue pilot study 40 subject Primary Insomnia subject randomize one 4 condition : 1 . QHS dose placebo 2 . QHS dose 10mg zolpidem 3 . Intermittent dose 10mg zolpidem ( 3-5 pill per week need ) 4 . Monitor condition .</detailed_description>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>Ages 25 55 stable sleep/wake schedule prefer sleep phase 10:00 p.m. 8:00 a.m . Patients Primary Insomnia meet diagnostic criterion Psychophysiologic Insomnia accord International Classification Sleep Disorders manual ( ICSD ) . complaint disturbed sleep must follow characteristic : &gt; 30 minute fall asleep , and/or &gt; 30 minute wake sleep onset time , total sleep time 6.5 hour ( sleep efficiency le 85 % ) , problem frequency &gt; 4 nights/ week problem duration &gt; 6 month . Unstable medical psychiatric illness Use medication may cause insomnia may reduce effectiveness zolpidem ( e.g . selective serotonin reuptake inhibitor ( SSRI 's ) , steroid , bronchodilator , calcium channel blocker , beta blocker , etc . ) symptom suggestive sleep disorder insomnia polysomnographic data indicate sleep disorder insomnia Evidence active illicit substance use fit criterion alcohol abuse dependence inadequate language comprehension pregnancy firstdegree relative bipolar disorder schizophrenia</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Insomnia</keyword>
	<keyword>Sleep</keyword>
	<keyword>zolpidem</keyword>
	<keyword>Ambien</keyword>
	<keyword>Hypnotics</keyword>
</DOC>